Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS
· Delayed Price · Currency is USD
0.1000
0.00 (0.00%)
Jun 6, 2025, 9:08 AM EDT
Nymox Pharmaceutical Market Cap
Nymox Pharmaceutical has a market cap or net worth of $9.45 million as of June 6, 2025. Its market cap has decreased by -74.66% in one year.
Market Cap
9.45M
Enterprise Value
12.67M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 9.45M, a decrease of -91.99%. That is a compound annual growth rate of -8.76%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.63B |
| Veradigm | 730.27M |
| Nika Pharmaceuticals | 666.65M |
| Tian'an Technology Group | 614.49M |
| Elite Pharmaceuticals | 597.81M |
| CytoDyn | 433.92M |
| Glass House Brands | 430.39M |
| Northwest Biotherapeutics | 384.07M |